BridgeMD
New treatment option for Anesthesia
Official title Anesthesia Induced Brain Cancer Survival (ABC Survival): A Feasibility Study
ClinicalTrials.gov ID: NCT04962672
What this study is testing
What is Propofol group?
Propofol group is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for anesthesia.
Also referred to as Total intravenous anesthesia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Cancer is a leading cause of death worldwide. It is estimated that approximately 55,000 Canadians are surviving with brain tumors.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient presenting between Jul 1, 2022 and Dec 28, 2023 for elective procedure
- Males or females of \>18 years
- Patient will be undergoing primary craniotomy (with general anesthesia) for suspected high-grade primary glial brain tumor (WHO grade III and IV)
You likely can't join if
- Patients of pediatric age group and pregnant patients
- Patients previously diagnosed with severe adrenal dysfunction (over activity or insufficiency)
- Suspected low grade (grade I, II), glioma, tumors involving brainstem and optic tract, and as well as non-glial tumors (i.e. suspected brain...
- Awake craniotomies
- Any conditions that preclude postoperative MRI
- Motor evoked potential monitoring or any other intraoperative condition that renders choice of anesthetics affected.
See the full eligibility criteria
- Patient presenting between Jul 1, 2022 and Dec 28, 2023 for elective procedure
- Males or females of \>18 years
- Patient will be undergoing primary craniotomy (with general anesthesia) for suspected high-grade primary glial brain tumor (WHO grade III and IV)
- Patients of pediatric age group and pregnant patients
- Patients previously diagnosed with severe adrenal dysfunction (over activity or insufficiency)
- Suspected low grade (grade I, II), glioma, tumors involving brainstem and optic tract, and as well as non-glial tumors (i.e. suspected brain metastasis)
- Awake craniotomies
- Any conditions that preclude postoperative MRI
- Motor evoked potential monitoring or any other intraoperative condition that renders choice of anesthetics affected.
- Recurrent GBM
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Ontario, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.